Dysphonia induced by vascular endothelium growth factor/vascular endothelium growth factor receptor inhibitors

Invest New Drugs. 2010 Dec;28(6):884-6. doi: 10.1007/s10637-009-9314-9. Epub 2009 Sep 16.

Authors

Dana M Hartl¹, Charles Ferté, Yohann Loriot, Carlos Gomez Roca, Rastislav Bahleda, Cristian Moldovan, Olivier Mir, Jean-Charles Soria

Affiliation

¹ Department of Otolaryngology Head & Neck Surgery, Institut Gustave Roussy, Paris, France. dana.hartl@igr.fr

PMID: 19756374
DOI: 10.1007/s10637-009-9314-9

No abstract available

MeSH terms

Acoustics
Adult
Aged
Antineoplastic Agents / adverse effects*
Antineoplastic Agents / pharmacology*
Dysphonia / chemically induced*
Dysphonia / physiopathology
Female
Humans
Larynx / abnormalities
Larynx / drug effects
Male
Middle Aged
Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors*
Receptors, Vascular Endothelial Growth Factor / metabolism
Vascular Endothelial Growth Factor A / antagonists & inhibitors*
Vascular Endothelial Growth Factor A / metabolism

Substances

Antineoplastic Agents
Vascular Endothelial Growth Factor A
Receptors, Vascular Endothelial Growth Factor